Literature DB >> 21547379

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.

Friederike Sixel-Döring1, Knut Liepe, Brit Mollenhauer, Ellen Trautmann, Claudia Trenkwalder.   

Abstract

(123)I-FP-CIT-SPECT is useful in the differential diagnosis of Parkinson's disease (PD) and tremor syndromes. Recently, there have been reports on normal nigrostriatal uptake of radio ligands in PD patients, referred to as scans without evidence of dopaminergic deficit (SWEDDs). Furthermore, a dopaminergic deficit has been described in some cases of different tremor types. We sought to clarify the occurrence of SWEDDs in PD and a possible association of various tremor types with PD. We performed a retrospective case analysis of 125 patients with diagnostically uncertain Parkinsonian or non-Parkinsonian tremor syndromes with clinical assessments and (123)I-FP-CIT-SPECT. A total of 36/40 (90%) patients with the predominant clinical feature of a postural and/or kinetic tremor showed normal DAT SPECT; 73/85 (86%) with predominant clinical symptoms of PD showed abnormal DAT SPECT with lower overall radio ligand uptake and a significant asymmetry contralateral to the clinically more affected side. In all, 4/40 (10%) of non-Parkinsonian tremor patients had abnormal DAT SPECT, but no corresponding asymmetry of radio ligand uptake. Probable essential tremor was considered clinically in follow-up assessments although final diagnosis of these four tremor cases remains inconclusive. A total of 12/85 (14%) clinically suspected PD patients had normal DAT SPECT (SWEDDs). Clinical reassessment identified two patients with dystonic tremor. Five patients with a positive response to levodopa remained unclear. In four cases of suspected PD with normal DAT SPECT, non-neurologic diseases were identified. One case showed a complete and spontaneous remission of symptoms. DAT SPECT offers an objective method to confirm or exclude a dopaminergic deficit in tremor predominant parkinsonism for clinically inconclusive cases. There was no evidence of a decrease in DAT binding in the majority of patients with postural and/or kinetic tremor. The striatal asymmetry index is a further helpful tool for differentiating PD from non-PD tremor syndromes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547379     DOI: 10.1007/s00415-011-6076-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

Authors:  P K Morrish; J S Rakshi; D L Bailey; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

Review 2.  Exploring the relationship between essential tremor and Parkinson's disease.

Authors:  Joohi Shahed; Joseph Jankovic
Journal:  Parkinsonism Relat Disord       Date:  2006-08-02       Impact factor: 4.891

3.  Levodopa can worsen tremor associated with dystonia.

Authors:  Davina J Hensman; Peter G Bain
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

4.  Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.

Authors:  P D Mozley; H J Kim; R C Gur; K Tatsch; L R Muenz; W T McElgin; M P Kung; M Mu; A M Myers; H F Kung
Journal:  J Nucl Med       Date:  1996-12       Impact factor: 10.057

5.  Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.

Authors:  Vicky L Marshall; Jim Patterson; Donald M Hadley; Katherine A Grosset; Donald G Grosset
Journal:  Nucl Med Commun       Date:  2006-12       Impact factor: 1.690

6.  123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Authors:  A Antonini; R Benti; R De Notaris; S Tesei; A Zecchinelli; G Sacilotto; N Meucci; M Canesi; C Mariani; G Pezzoli; P Gerundini
Journal:  Neurol Sci       Date:  2003-10       Impact factor: 3.307

7.  Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD.

Authors:  E D Louis; G Levy; H Mejia-Santana; L Cote; H Andrews; J Harris; C Waters; B Ford; S Frucht; S Fahn; R Ottman; K Marder
Journal:  Neurology       Date:  2003-10-14       Impact factor: 9.910

Review 8.  Role of DAT-SPECT in the diagnostic work up of parkinsonism.

Authors:  Christoph Scherfler; Johannes Schwarz; Angelo Antonini; Donald Grosset; Francesc Valldeoriola; Kenneth Marek; Wolfgang Oertel; Eduardo Tolosa; Andrew J Lees; Werner Poewe
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

Review 9.  Essential tremor--neurodegenerative or nondegenerative disease towards a working definition of ET.

Authors:  Günther Deuschl; Rodger Elble
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 10.  Is there a relationship between Parkinson's disease and essential tremor?

Authors:  R Pahwa; W C Koller
Journal:  Clin Neuropharmacol       Date:  1993-02       Impact factor: 1.592

View more
  21 in total

1.  Distinct spatiotemporal patterns for disease duration and stage in Parkinson's disease.

Authors:  Simon Badoud; Nicolas Nicastro; Valentina Garibotto; Pierre R Burkhard; Sven Haller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-29       Impact factor: 9.236

2.  Clinical routine use of dopamine transporter imaging in 516 consecutive patients.

Authors:  Claire Thiriez; Emmanuel Itti; Gilles Fénelon; Eva Evangelista; Michel Meignan; Pierre Cesaro; Philippe Remy
Journal:  J Neurol       Date:  2015-02-04       Impact factor: 4.849

3.  The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study.

Authors:  Kimberly D Seifert; Jonathan I Wiener
Journal:  Am J Neurodegener Dis       Date:  2013-03-08

4.  Screening for dopa-responsive dystonia in patients with Scans Without Evidence of Dopaminergic Deficiency (SWEDD).

Authors:  Anna De Rosa; Claudia Carducci; Carla Carducci; Silvio Peluso; Maria Lieto; Andrea Mazzella; Francesco Saccà; Vincenzo Brescia Morra; Sabina Pappatà; Vincenzo Leuzzi; Giuseppe De Michele
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

5.  Dopamine transporter imaging in essential tremor with and without parkinsonian features.

Authors:  Olga Waln; Ying Wu; Reid Perlman; Juliet Wendt; Anh K Van; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2015-07-02       Impact factor: 3.575

6.  Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors:  Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2013-01-24       Impact factor: 3.575

7.  Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Whan Cho; Young Hwan Kim; Ji Young Kim; Yun Young Choi; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2012-11-24       Impact factor: 3.307

8.  A role for accelerometry in the differential diagnosis of tremor syndromes.

Authors:  F Bove; G Di Lazzaro; D Mulas; F Cocciolillo; D Di Giuda; A R Bentivoglio
Journal:  Funct Neurol       Date:  2018 Jan/Mar

9.  Establishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions.

Authors:  Nicolas Nicastro; Valentina Garibotto; Antoine Poncet; Simon Badoud; Pierre R Burkhard
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

Review 10.  Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis.

Authors:  Danny Bega; Phillip H Kuo; Anastasia Chalkidou; Mariusz T Grzeda; Thomas Macmillan; Christine Brand; Zulfiqar H Sheikh; Angelo Antonini
Journal:  NPJ Parkinsons Dis       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.